DOSE Share Price Performance
Recent DOSE News & Updates
No updates
Rapid Dose Therapeutics Corp. Key Details
Last Reported Earnings
May 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.037
- Gross Margin
- 53.26%
- Net Profit Margin
- -197.30%
- Debt/Equity Ratio
- -51.3%
Rapid Dose Therapeutics Corp. Competitors
About DOSE
- Founded
- n/a
- Employees
- n/a
- CEO
- WebsiteView website
Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies in Canada. The company offers QuickStrip/PharmaStrip, an oral fast-dissolving drug delivery system to rapidly release into the blood stream a list of pharmaceuticals, emulsified oils, and over-the-counter medicines; QuickStrip Energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12 in the system; and QuickStrip sleep that delivers melatonin in the system, as well as dental products. It also engages in the research, production, provision, and distribution of technical services for the delivery of oral thin film strips that consists of active ingredients. In addition, the company sells health and wellness products, such as nutraceuticals and infused soaps; and white label manufacturing, including oral thin film strips containing active ingredients under cannabis licensing, as well as provides consulting services for the application of active ingredients. Rapid Dose Therapeutics Corp. is headquartered in Burlington, Canada.
Canadian Market Performance
- 7 Days: -1.7%
- 3 Months: 8.2%
- 1 Year: 18.6%
- Year to Date: 8.7%
Over the last 7 days, the market has dropped 1.7%, driven by a loss of 2.5% in the Financials sector. In contrast to the last week, the market is actually up 19% over the past year. Earnings are forecast to grow by 11% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading